INS and type 2 diabetes mellitus: A current National Insulin Summit (NIS) consensus from India reports that insulin therapy is the most effective antidiabetic agent and can reduce A1C by 1.5–3.5% from baseline when used as monotherapy in T2DM patients, whereas other antidiabetic agents can only reduce A1C to a range of 0.5–2.0% [16].